Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesLong-term treatment with oral ketamine. Case report of a female patient with therapy-resistant post-herpetic neuralgia
Schmerz, 09/18/09
Zimmer C et al. – Postherpetic neuralgia can lead to therapy–resistant neuropathic pain. The authors report the case of a 74–year–old woman with postherpetic perineal neuralgia resistant to opioids and antiepileptic drugs who has been successfully treated with oral ketamine for 28 months. Pain scores were reduced by more than 50%, despite dose reduction of other analgetic drugs. Significant side effects have not yet been reported. Despite “off–label” use, ketamine is an important third line option in cases of therapy–resistant neuropathic pain.
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Use of oral ketamine in chronic pain management: A review
European Journal of Pain, 11/02/09
Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial
Diabetic Medicine, 10/01/09
Acute back pain: benefits and risks of current treatments
Current Medical Research and Opinion, 11/19/09
Sponsor
Article Search
Sponsor